MAGNESIUM DEFICIENCY IN PATHOGENESIS OF CARDIOVASCULAR DISEASES: RECENT DEVELOPMENTS
https://doi.org/10.15829/1560-4071-2017-6-167-172
Abstract
The review focuses on the influence of magnesium deficiency on a variety of cardiovascular pathogenetic chains. The issues especially considered are vessel tone regulation, endothelial function, atherogenesis and atherothrombosis, as the functioning of cardiac conduction system. These mechanisms, disordered, lead to initiation and progression of the disorders as essential hypertension, chronic heart failure and coronary heart disease. Also, the data systematized, on the role of magnesium homeostasis correction for prevention and treatment of these pathologies.
About the Authors
D. E. Maylian
M. Gorky Donetsk National Medical University
Ukraine
Competing Interests: Конфликт интересов не заявляется.
Ukraine
Competing Interests: Конфликт интересов не заявляется.
V. V. Kolomiets
M. Gorky Donetsk National Medical University
Ukraine
Competing Interests: Конфликт интересов не заявляется.
Ukraine
Competing Interests: Конфликт интересов не заявляется.
References
1. Russia in figures. 2016: Statistical handbook. Moscow: Rosstat, 2016. p. 545. Russian (Россия в цифрах. 2016: Краткий статистический сборник. Москва: Росстат, 2016. 545 c.)
2. Starostin I.V. Place of Magnesium Salts in the Treatment of Cardiovascular Disease. Cardiology 2012; 52(8): 83-8. Russian (Старостин И.В. Место магния в терапии сердечно-сосудистых заболеваний. Кардиология 2012; 52(8): 83-8).
3. Gröber U, Schmidt J, Kisters K. Magnesium in Prevention and Therapy. Nutrients 2015; 7(9): 8199–226.
4. Nielsen FH, Johnson LA. Data from Controlled Metabolic Ward Studies Provide Guidance for the Determination of Status Indicators and Dietary Requirements for Magnesium. Biol Trace Elem Res. 2016; published online 24 Oct 2016. http://link.springer.com/article/10.1007%2Fs12011-016-0873-2. DOI: 10.1007/s12011-016-0873-2.
5. Jahnen-Dechent J, Ketteler M. Magnesium basics. Clin Kidney J 2012; 5: 3–14.
6. Gröber U. Magnesium. In Micronutrients: Metabolic Tuning-Prevention-Therapy, 1st ed. Stuttgart, Germany: MedPharm Scientific Publishers, 2009: 159-66.
7. Cohen L. Physiologic assessment of magnesium status in humans: a combination of load retention and renal excretion. IMAJ 2006; 2: 938-9.
8. Gröber U. Interactions between drugs and micronutrients. Med Monatsschr Pharm 2006; 29: 26–35.
9. Gromova OA, Torshin IYu, Yudina NV et al. Magnesium Deficiency and Dysregulation of Vascular Tone. Cardiology 2014; 7: 66-72. Russian (Громова О.А., Торшин И.Ю., Юдина Н.В. и др. Дефицит магния и нарушения регуляции тонуса сосудов. Кардиология. 2014; 7: 66-72).
10. Fatih Kircelli, Mirjam E. Peter, Ebru Sevinc Ok, et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 2012; 27(2): 514–21.
11. Montes AO, Guerrero F, Martinez-Moreno JM et al. Magnesium Inhibits Wnt/β-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells. PLoS One 2014; 9(2): e89525.
12. Monalisa Das, Patralekha Ray Chaudhuri, Badal C. Mondal, Sukumar Mitra, Debasmita Bandyopadhyay, Sushobhan Pramanik Assessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen Indian J Pharmacol 2015; 47(5): 502–508.
13. Shechter M, Bairey Merz CN, Stuehlinger HG et al. Oral magnesium supplementation improves exercise duration and quality of life in patients with coronary artery disease. Am J Cardiol 2003; 91: 517-21.
14. Pokan R, Hofmann P, von Duvillard SP et al. Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients. Br J Sports Med. 2006; 40: 773-8.
15. Lerman A, Zeiher AM. Endothelial function cardiac events. Circulation 2005; 111: 363-8.
16. Shechter M, Sherer Y. Endothelial dysfunction: a crystal ball prediction for enhanced cardiovascular risk? Isr Med Assoc J 2003; 5: 736-8.
17. Paravicini TM, Yogi A, Mazur A, Touyz RM. Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia. Hypertension 2009; 53: 423-9.
18. Song Y, Li TY, van Dam RM, et al. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr. 2007; 85: 1068-74.
19. Chacko SA, Song Y, Nathan L et al. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 2010; 33: 304-10.
20. Kieboom BC, Niemeijer MN, Leening MG et al. Hoorn serum magnesium and the risk of death from coronary heart disease and sudden cardiac death. J Am Heart Assoc 2016; 5(1): e002707.
21. Amighi J, Sabeti S, Schlager O et al. Low serum magnesium predicts neurological events in patients with advanced atherosclerosis. Stroke 2004; 35: 22-7.
22. Pachikian BD, Neyrinck AM, Deldicque L et al. Changes in intestinal bifidobacteria levels are associated with the inflammatory response in magnesium-deficient mice. J Nutr 2010; 140: 509-14.
23. Lin CY, Tsai PS, Hung YC, Huang CJ. L-type calciumchannels are involved in mediating the anti-inflammatory effects of magnesium sulphate. Br J Anaesth 2010; 104: 44-51.
24. King DE. Inflammation and elevation of C-reactive protein: does magnesium play a key role? Magnes Res 2009; 22: 57-9.
25. Kieboom BC, Niemeijer MN, Leening MG et al. Hoorn Inadequate dietary magnesium intake increases atherosclerotic plaque development in rabbits. J Am Heart Assoc 2016; 5(1): e002707.
26. Fu ZY, Yang FL, Hsu HW, Lu YF. Drinking deep seawater decreases serum total and low-density lipoprotein–cholesterol in hypercholesterolemic subjects. J Med Food 2012; 15(6): 535–41.
27. Chen Y, Wang X, Shen Z et al. Effects of dietary components on high-density lipoprotein measures in a cohort of 1,566 participants. Lipids Health Dis. 2015; 20: 14-34.
28. Corretti MC, Anderson TJ, Benjamin EJ, et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery. J Am Coll Cardiol 2002; 39: 257-65.
29. Rukshin V, Shah PK, Cercek B et al. Comparative antithrombotic effects of magnesium sulfate and platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis. Circulation 2002; 105: 1970-5.
30. An G, Du Z, Meng X et al. Association between low serum magnesium level and major adverse cardiac events in patients treated with drug-eluting stents for acute myocardial infarction. PLoS One 2014; 9(6): e98971.
31. Vierling W, Liebscher DH, Micke O et al. Magnesium deficiency and therapy in cardiac arrhythmias: Recommendations of the German Society for Magnesium Research. Deutsch. Med. Wochenschr 2013; 138: 1165–71.
32. Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnes Res 2010; 23: 194–8.
33. Gao X, Peng L, Adhikari CM et al. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. J Card Fail 2007; 13: 170–7.
34. Povoroznyuk V.V., Snezhitskiy V.A., Yankouskaya L.V. et al. Extraskeletal effects of vitamin D: role in the pathogenesis of cardiovascular diseases. Journal of the Grodno State Medical University 2015; 2(50): 6-15. Russian (Поворознюк В.В., Снежицкий В.А., Янковская Л.В. и др. Значение витамина D в патогенезе сердечно-сосудистых заболеваний. Журнал Гродненского государственного медицинского университета 2015; 2(50): 6-15.)
35. Rosanoff А, Dai Qi, Shapses SA Essential Nutrient Interactions: Does Low or Suboptimal Magnesium Status Interact with Vitamin D and/or Calcium Status? American Society for Nutrition. Adv Nutr 2016; 7: 25–43.
36. Shah NC, Shah JG, Li Z et al. Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging. Int. J. Clin. Exp. Med. 2014; 7: 497–514.
37. Shechter M, Shechter A. Magnesium and myocardial infarction. Clin Calcium 2005; 11: 111-5.
38. Kolomiyets V.V., Mailian D.E., Tretyak L.A. et al. Influence of renal calcium and magnesium egestion optimization on diuretics antihypertensive and cardioprotective properties. Belgorod State University Scientific Bulletin Medicine Pharmacy 2015; 10(207): 63-9. Russian (Коломиец В.В., Майлян Д.Э., Третяк Л.А. и др. Влияние оптимизации почечной экскреции кальция и магния на антигипертензивные и кардиопротекторные свойства диуретиков. Научные ведомости Белгородского государственного университета. Серия: Медицина. Фармация 2015; 10(207): 63-9).
39. Adamopoulos C, Pitt B, Sui X et al. Low serum magnesium and cardiovascular mortality in chronic heart failure: A propensitymatched study. Intern J Cardio 2009; 136: 270-7.
40. Stepura OB, Martynow AI. Magnesium orotate in severe congestive heart failure (MACH). Intern J Cardiol 2009; 131: 293-5.
41. Kisters K, Gremmler B, Gröber U. Natriuretic peptides, hypertension, heart insufficiency and magnesium. Adv Tech Biol Med 2015; 3: 134.
42. Kisters K, Gremmler B, Gröber U. Magnesium deficiency in hypertensive heart disease. J Hypertens 2015; 33: e273.
Supplementary files
|
|
1. Сопроводительное письмо | |
| Subject | ||
| Type | Other | |
View
(1MB)
|
Indexing metadata ▾ | |
|
2. Титульный лист | |
| Subject | ||
| Type | Other | |
Download
(16KB)
|
Indexing metadata ▾ | |
Review
For citations:
Maylian D.E., Kolomiets V.V. MAGNESIUM DEFICIENCY IN PATHOGENESIS OF CARDIOVASCULAR DISEASES: RECENT DEVELOPMENTS. Russian Journal of Cardiology. 2017;(6):167-172. (In Russ.) https://doi.org/10.15829/1560-4071-2017-6-167-172
Views:
966
Email this article 